SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is trending following news of its Snapdragon Ride Pilot system launching in BMW's iX3, highlighting increased automotive revenue and a push into ADAS. The community is discussing the potential for this and upcoming Snapdragon Summit announcements to drive the stock higher, with some eyeing a move towards long-term resistance levels. Bullish sentiment is fueled by Qualcomm's attractive valuation compared to its peers.

Energy Fuels, Inc. is a mining development company, which engages in the exploration and evaluation of uranium and vanadium properties. It also operates the Nichols Ranch, Alta Mesa, and White Mesa Mill projects. The company was founded by George E. L. Glasier and John David Mason on June 24, 1987 and is headquartered in Lakewood, CO.

Energy Fuels Inc

Energy Fuels is trending amid discussions around rare earth elements and a recent deal with Australia, potentially positioning the company to benefit from efforts to reduce reliance on China. Community members are actively debating the impact of this deal, analyzing options flow, and speculating on potential catalysts such as government contracts, with some expressing concerns about dilution. Technical analysis and trading strategies are also being heavily discussed, with many participants closely watching for key price levels.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

UAMY is trending as investors discuss its volatile price action and potential acquisition of Larvotto Resources, with some expressing concerns about valuation and dilution. Community members are weighing the impact of US-China trade relations and the company's strategic position in antimony production, particularly in light of government contracts and expansion plans. Bullish investors are accumulating shares, anticipating future growth and potential government support for UAMY's role in securing domestic supply chains.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

Click Holdings (CLIK) is trending due to renewed trading momentum following a report of strong revenue growth, sparking discussions of a potential short squeeze given its low float. The community is weighing the impact of insider ownership and potential for high volatility. Some traders are highlighting the stock's potential for significant gains, while others caution about its history and risk of dilution.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending as the stock plunges following a pause in clinical trials due to a patient developing liver problems, sparking discussions about the safety of gene editing and its impact on the sector. While some investors are concerned about the potential long-term implications, others view the overreaction as a buying opportunity, emphasizing the long-term potential of CRISPR technology and the company's pipeline. Community members are debating whether the trial pause is a temporary setback or a more serious issue, with some pointing to the patient's age and BMI as contributing factors.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

SNDX is trending as investors discuss its potential in the menin inhibitor space alongside competitor KURA, weighing its two FDA-approved drugs and revenue against KURA's upcoming PDUFA. Community members are highlighting SNDX's high short interest, potential buyout scenarios, and upcoming earnings as factors driving current interest. Some traders are debating the impact of FDA label expansion and a boxed warning on future growth.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

IMG Crypto is trending as the community buzzes about passive income opportunities through holding and earning Solana rewards. Discussions highlight the project's ongoing development, including participation in a Solana hackathon, and the potential for transparent, community-driven growth within the DeFi space. Some users express skepticism, while others voice strong conviction in the project's long-term potential and unique reward system.

DZZ provides -2x the daily performance of futures contracts relating to gold. The notes index selects contracts based on the shape of the futures curve to minimize contango.

Deutsche Bank AG London - DB Gold Double Short ETN

PowerShares DB Gold Double Short ETN

DZZ is trending due to discussions around potential gains as a double short gold ETF, with community members pointing to gold's struggles and anticipating further downward movement. Some traders highlight technical indicators suggesting a possible squeeze, while others reference broader market conditions and their potential impact on gold prices. Overall, the sentiment leans towards DZZ benefiting from a bearish outlook on gold.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending due to its newly announced NFL apparel partnership with Fanatics, sparking mixed reactions; while some investors see it as a growth opportunity, others question the brand's direction. The community is actively debating the potential impact of the deal, with some expressing concerns about short sellers and possible manipulation amidst overall bearish sentiment related to the stock's recent performance.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as discussions revolve around its potential breakout and the upcoming vote on Elon Musk's compensation package, with some believing approval is crucial for the company's future. Community debates center on Tesla's valuation, profitability, and the impact of Musk's leadership and AI advancements. Traders are actively monitoring key price levels, anticipating volatility and potential shorting opportunities if certain resistance levels hold.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Integer (ITGR) Beats Q3 Earnings and Revenue Estimates

Integer (ITGR) delivered earnings and revenue surprises of +6.55% and +0.41%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

What Makes SINTX TECHNOLOGIES, INC. (SINT) a Strong Momentum Stock: Buy Now?

Does SINTX TECHNOLOGIES, INC. (SINT) have what it takes to be a top stock pick for momentum investors? Let's find out.

Sensus Healthcare, Inc. (SRTS) Reports Q2 Loss, Misses Revenue Estimates

Sensus Healthcare (SRTS) delivered earnings and revenue surprises of -700.00% and -16.88%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Intuitive Surgical, Inc. (ISRG) Q2 Earnings and Revenues Top Estimates

Intuitive Surgical (ISRG) delivered earnings and revenue surprises of +14.06% and +3.93%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Retail chatter around Sintx Technologies surged on Thursday following the company's announcement of a newly issued international patent and the formation of a wholly-owned agribiotech subsidiary.Sintx Technologies closed 8.3% lower at $2.81 on Thursday, with shares slipping another 3.2% to $2.72 in after-hours trading.The advanced ceramics developer for medical applications said it has received an international Patent, which protects the antimicrobial applications of its silicon nitride compound within agricultural environments.&nbsp;The patent forms part of a broader intellectual property portfolio addressing the antimicrobial crop protection market.SINTX also announced the establishment of Sintx Agribiotech Inc., an independently operated unit tasked with developing and commercializing silicon nitride-based technologies for agricultural and environmental applications.&nbsp;The subsidiary will operate separately from the firm’s core medical device business and have its own management team.CEO Eric Olson said the company sees wine production as one of the most promising early applications for the new technology.Internal research previously published by the company showed that silicon nitride reduced the growth and sporulation of Plasmopara viticola, the pathogen responsible for grapevine downy mildew, by up to 90% on grape varieties such as Cabernet Sauvignon and Cannonau.&nbsp;The study indicated that silicon nitride caused no phytotoxic effects and may offer a sustainable alternative to copper-based fungicides, which face increasing regulatory scrutiny.On Stocktwits, retail sentiment was ‘extremely bullish’ amid a 7,500% surge in 24-hour message volume.One user viewed the recent pullback in Sintx shares as overextended and suggested accumulating the stock below key price levels.<stembedurl>https://stocktwits.com/amda/message/615507468</stembedurl>Meanwhile, another user drew parallels to a previous patent-related move in February that preceded a brief rally.<stembedurl>https://stocktwits.com/MathiasMatheson/message/615511807</stembedurl>The stock has declined 23% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Sintx Technologies Draws Heavy Retail Buzz On New Patent Push, Subsidiary

The company announced the issuance of an international patent for its silicon nitride’s antimicrobial agricultural uses and launched a separate agribiotech subsidiary to commercialize these technologies.

Equity

This Penny Stock Is Surging on Patent News. Analysts Think It Gain 1,300% From Here.

SINT stock is up nearly 60% after receiving a new U.S. patent on Wednesday. Analysts see exceptional further upside in SINT from current levels.

Why SINTX Technologies Stock Is Up 50%

SINTX Technologies shares are trading higher by 55% Monday morning. The company announced plans to buy back up to $500K worth of common stock.
read more...

Shares of ceramic manufacturer SINTX Technologies Inc (SINT) more than doubled on Monday, rising a whopping 114%, after the company notified that it has received a notice of allowance for a patent application.SINTX said the patent covers novel methods of bonding bioactive silicon nitride or mixtures of silicon nitride and bioactive glass to zirconia-toughened alumina and similar material surfaces.&nbsp; This invention is designed to impart silicon nitride’s beneficial biomedical properties to relatively biologically inert ZTA substrates.The company said it has recently developed a particulate form of its silicon nitride that can be used in composites and coatings.&nbsp;The firm explained that when compounded with or applied to the surface of conventional inert biomaterials, silicon nitride’s improved “osseointegration" and resistance to bacterial colonization can be conferred to the resulting device. Another benefit of the coating method is that it allows for potential refinishing of existing devices to upgrade their functionality, it said.Following the announcement, SINTX became the second-most trending ticker on Stocktwits with the sentiment meter flipping into the ‘bullish’ territory (60/100) from the ‘neutral’ zone. The move was accompanied by ‘high’ message&nbsp;volumes.<figure class="image"><a href="https://stocktwits.com/symbol/SINT"><img style="aspect-ratio:1884/530;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_09_09_at_11_12_23_AM_91cb3a9a98.png" alt="SINTX sentiment meter as of 10:53 a.m. ET on Sept. 09, 2024" width="1884" height="530"></a><figcaption>SINTX sentiment meter as of 10:53 a.m. ET on Sept. 09, 2024</figcaption></figure>Last week, the firm announced the completion of the first series of strategic initiatives aimed at strengthening its financial position and enhancing its long-term growth prospects.The firm raised additional capital through the sale of common stock under its at-the-market (ATM) offering. It cut down expenses such that it will result in an over 50% reduction in cash used in operating expenses, lowering expected future annual expenses by approximately $5.8 million.The firm said it has also initiated discussions with its lessors, aiming to reduce its lease obligations by the end of 2024.Despite the massive rally in the firm’s shares on Monday, the stock is still down over 92% since the beginning of the year. Bullish followers of the stock are expressing optimism on the latest development.<stembedurl>https://stocktwits.com/RSolo87/message/585439374</stembedurl>However, it is noteworthy that the stock has lost over 99% of its value in the last five years. Investors will also be watching out whether the firm manages to reap the benefits of its strategic initiatives to claw back some of its lost market capitalization.

Last week, SINTX Technologies announced the completion of the first series of strategic initiatives aimed at strengthening its financial position

SINTX Technologies Stock More Than Doubles As Firm Receives Notice Of Allowance For Patent Application

SINTX said the patent covers novel methods of bonding bioactive silicon nitride or mixtures of silicon nitride and bioactive glass to zirconia-toughened alumina and similar material surfaces.

Why SINTX Technologies Stock Is Falling

SINTX Technologies shares are trading lower by 14% during Friday's session. The company on Thursday announced a 1-for-200 reverse stock split.
read more...

Why SiNtx Technologies Stock Is Soaring

According to SEC filings, Sintx shareholders approved a proposed reverse stock split of all of the company's issued and outstanding shares at a ratio of not less than 1-for-100 and not greater than...

SINTX Technologies, Inc. is a ceramics company, which engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. The company was founded by Aaron A. Hofmann and Ashok C. Khandkar in December 1996 and is headquartered in Salt Lake City, UT.

SINTX Technologies Inc

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

SINT
SINTX Technologies Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest SINT News

SINTSINTX Technologies Inc